Isoniazid conjugated poly(lactide-co-glycolide): Long-term controlled drug release and tissue regeneration for bone tuberculosis therapy

Biomaterials

Volumn 52, Issue 1, 2015, Pages 417-425

  Huang, Da ^a   Li, Dawei ^b,c   Wang, Tiantian ^b   Shen, Hong ^a   Zhao, Pei ^a   Liu, Baoxia ^a   You, Yezi ^d   Ma, Yuanzheng ^b,c   Yang, Fei ^a   Wu, Decheng ^a   Wang, Shenguo ^a  

^a INSTITUTE OF CHEMISTRY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Bone repair; Bone tuberculosis; Drug delivery; Isoniazid; Scaffolds

Indexed keywords

BIOCOMPATIBILITY; BONE; CHEMOTHERAPY; DRUG DELIVERY; HYDRAZINE; SCAFFOLDS; TUBES (COMPONENTS);

BONE REPAIR; COMPOSITE SCAFFOLDS; CONTROLLED DRUG RELEASE; DRUG CONCENTRATION; DRUG CONTROLLED RELEASE; DRUG DELIVERY SYSTEM; ISONIAZID; POLY LACTIDE-CO-GLYCOLIDE;

TISSUE REGENERATION;

ISONIAZID; POLYGLACTIN; BIOMATERIAL; DRUG CARRIER; HYDRAZONE DERIVATIVE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BONE REGENERATION; CONTROLLED DRUG RELEASE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LONG TERM CARE; NANOFABRICATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE REGENERATION; TUBERCULOUS OSTEOMYELITIS; WORK; 3T3 CELL LINE; ANIMAL; BONE; CHEMISTRY; DRUG EFFECTS; FEMALE; MALE; MECHANICAL STRESS; MOUSE; PATHOLOGY; PROCEDURES; RABBIT; RADIUS; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUBERCULOSIS, OSTEOARTICULAR;

ORYCTOLAGUS CUNICULUS;

3T3 CELLS; ANIMALS; ANTITUBERCULAR AGENTS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FEMALE; HYDRAZONES; ISONIAZID; MALE; MICE; POLYGLACTIN 910; RABBITS; RADIUS; STRESS, MECHANICAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TUBERCULOSIS, OSTEOARTICULAR;

EID: 84932614735     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.052     Document Type: Article

References (50)

1. Fox G.J., Barry S.E., Britton W.J., Marks G.B. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013, 41:140-156.
2. Glaziou P., Falzon D., Floyd K., Raviglione M. Global epidemiology of tuberculosis preface. Sem Resp Crit Care M 2013, 34:3-16.
3. Dye C. Global epidemiology of tuberculosis. Lancet 2006, 367:938-940.
4. World Health Organization Global tuberculosis report World health organization 2013 2013.
5. Magnussen A., Dinneen A., Ramesh P. Osteoarticular tuberculosis: increasing incidence of a difficult clinical diagnosis. Brit J Gen Pract 2013, 63:385-386.
6. Malaviya A.N., Kotwal P.P. Arthritis associated with tuberculosis. Best Pract Res Cl Rh 2003, 17:319-343.
7. Pigrau S.C., Rodriguez P.D. Bone and joint tuberculosis. Eur Spine J 2013, 22:556-566.
8. Li L., Xu J., Ma Y., Tang D., Chen Y., Luo F., et al. Surgical strategy and management outcomes for adjacent multisegmental spinal tuberculosis. Spine 2014, 39. E40-E8.
9. Sequeira W., Co H., Block J.A. Osteoarticular tuberculosis: current diagnosis and treatment. Am J Ther 2000, 7:393-398.
10. Falzon D., Jaramillo E., Schunemann H.J., Arentz M., Bauer M., Bayona J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011, 38:516-528.
11. Bass J.B., Farer L.S., Hopewell P.C., Obrien R., Jacobs R.F., Ruben F., et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Resp Crit Care 1994, 149:1359-1374.
12. Garrido G., Gomezreino J.J., Fernandezdapica P., Palenque E., Prieto S. Areview of peripheral tuberculous arthritis. Semin Arthritis Rheu 1988, 18:142-149.
13. Suarez G.I., Noguerado A. Drug treatment of multidrug-resistant osteoarticular tuberculosis: a systematic literature review. Int J Infect Dis 2012, 16. E774-E8.
14. Yew W.W., Leung C.C. Antituberculosis drugs and hepatotoxicity. Respirology 2006, 11:699-707.
15. Schaberg T. The dark side of antituberculosis therapy - adverse events involving liver-function. Eur Respir J 1995, 8:1247-1249.
16. Mehanna M.M., Mohyeldin S.M., Elgindy N.A. Respirable nanocarriers as a promising strategy for antitubercular drug delivery. JControl Release 2014, 187:183-197.
17. Zhu M., Wang H.X., Liu J.Y., He H.L., Hua X.G., He Q.J., et al. Amesoporous silica nanoparticulate/beta-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy. Biomaterials 2011, 32:1986-1995.
18. Rastogi N., Labrousse V., Goh K.S. Invitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 1996, 33:167-175.
19. Brossier F. Mechanisms of action and resistance to INH, a first-line antituberculous drug. JAnti-Infect 2011, 13:217-227.
20. World Health Organization Global tuberculosis report World health organization 2012 2012.
21. Kaur I.P., Singh H. Nanostructured drug delivery for better management of tuberculosis. JControl Release 2014, 184:36-50.
22. Li B., Gao Y., Feng Y., Ma B., Zhu R., Zhou Y. Formation of concentric multi-layer chitosan hydrogel loaded with isoniazid. JControl Release 2011, 152(1). e45-e7.
23. Bhandari R., Kaur I.P. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm 2013, 441:202-212.
24. Dong J.F., Zhang S.M., Liu H.M., Li X.Z., Liu Y.H., Du Y.Y. Novel alternative therapy for spinal tuberculosis during surgery: reconstructing with anti-tuberculosis bioactivity implants. Expert Opin Drug Del 2014, 11:299-305.
25. Tuli S.M. General principles of osteoarticular tuberculosis. Clin Orthop Relat R 2002, 11-19.
26. Wang X.Y., Pang X.Y., Wu P., Luo C.K., Shen X.J. One-stage anterior debridement, bone grafting and posterior instrumentation vs single posterior debridement, bone grafting, and instrumentation for the treatment of thoracic and lumbar spinal tuberculosis. Eur Spine J 2014, 23:830-837.
27. He M.L., Xu H., Zhao J.M., Wang Z. Anterior debridement, decompression, bone grafting, and instrumentation for lower cervical spine tuberculosis. Spine J 2014, 14:619-627.
28. Lin C.Y., Chang Y.H., Li K.C., Lu C.H., Sung L.Y., Yeh C.L., et al. The use of ASCs engineered to express BMP2 or TGF-beta 3 within scaffold constructs to promote calvarial bone repair. Biomaterials 2013, 34:9401-9412.
29. Cancedda R., Giannoni P., Mastrogiacomo M. Atissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007, 28:4240-4250.
30. Harada N., Watanabe Y., Sato K., Abe S., Yamanaka K., Sakai Y., et al. Bone regeneration in a massive rat femur defect through endochondral ossification achieved with chondrogenically differentiated MSCs in a degradable scaffold. Biomaterials 2014, 35:7800-7810.
31. Chang N.J., Lin C.C., Li C.F., Wang D.A., Issariyaku N., Yeh M.L. The combined effects of continuous passive motion treatment and acellular PLGA implants on osteochondral regeneration in the rabbit. Biomaterials 2012, 33:3153-3163.
32. Xie S.J., Zhu Q., Wang B., Gu H.J., Liu W., Cui L., et al. Incorporation of tripolyphosphate nanoparticles into fibrous poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2010, 31:5100-5109.
33. Lickorish D., Guan L., Davies J.E. Athree-phase, fully resorbable, polyester/calcium phosphate scaffold for bone tissue engineering: evolution of scaffold design. Biomaterials 2007, 28:1495-1502.
34. Cao H., Kuboyama N. Abiodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering. Bone 2010, 46:386-395.
35. Inzana J.A., Olvera D., Fuller S.M., Kelly J.P., Graeve O.A., Schwarz E.M., et al. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 2014, 35:4026-4034.
36. Kim S.S., Park M.S., Jeon O., Choi C.Y., Kim B.S. Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006, 27:1399-1409.
37. Liu B., Zhou X., Yang F., Shen H., Wang S., Zhang B., et al. Fabrication of uniform sized polylactone microcapsules by premix membrane emulsification for ultrasound imaging. Polym Chem 2014, 5:1693-1701.
38. Hu X., Shen H., Yang F., Liang X., Wang S., Wu D. Modified composite microspheres of hydroxyapatite and poly(lactide-co-glycolide) as an injectable scaffold. Appl Surf Sci 2014, 292:764-772.
39. Yang F., Qu X., Cui W., Bei J., Yu F., Lu S., et al. Manufacturing and morphology structure of polylactide-type microtubules orientation-structured scaffolds. Biomaterials 2006, 27:4923-4933.
40. Zheng L.Q., Yang F., Shen H., Hu X.F., Mochizuki C., Sato M., et al. The effect of composition of calcium phosphate composite scaffolds on the formation of tooth tissue from human dental pulp stem cells. Biomaterials 2011, 32:7053-7059.
41. Kondo N., Ogose A., Tokunaga K., Ito T., Arai K., Kudo N., et al. Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle. Biomaterials 2005, 26:5600-5608.
42. Yang F., Cui W.J., Xiong Z., Liu L., Bei J.Z., Wang S.G. Poly(L,L-lactide-co-glycolide)/tricalcium phosphate composite scaffold and its various changes during degradation invitro. Polym Degrad Stab 2006, 91:3065-3073.
43. Cai Q., Zhao Y.L., Bei J.Z., Xi F., Wang S.G. Synthesis and properties of star-shaped polylactide attached to poly(amidoamine) dendrimer. Biomacromolecules 2003, 4:828-834.
44. Dong C.M., Qiu K.Y., Gu Z.W., Feng X.D. Synthesis of star-shaped poly(D,L-lactic acid-alt-glycolic acid) with multifunctional initiator and SnOct2 catalyst. Polymer 2001, 42:6891-6896.
45. Tu C.F., Cai Q., Yang J., Wan Y.Q., Bei J.Z., Wang S. The fabrication and characterization of poly(lactic acid) scaffolds for tissue engineering by improved solid-liquid phase separation. Polym Adv Technol 2003, 14:565-573.
46. Kricheldorf H.R., Kreiser-Saunders I., Stricker A. Polylactones 48. SnOct2-initiated polymerizations of lactide: a mechanistic study. Macromolecules 2000, 33:702-709.
47. Ozcelik B., Blencowe A., Palmer J., Ladewig K., Stevens G.W., Abberton K.M., et al. Highly porous and mechanically robust polyester poly(ethylene glycol) sponges as implantable scaffolds. Acta Biomater 2014, 10:2769-2780.
48. Deplaine H., Acosta V.A., Vidaurre A., Ribelles J.L.G., Doblare M., Ochoa I., et al. Evolution of the properties of a poly(L-lactic acid) scaffold with double porosity during invitro degradation in a phosphate-buffered saline solution. JAppl Polym Sci 2014, 131:40956.
49. Wu C., Miron R., Sculean A., Kaskel S., Doert T., Schulze R., et al. Proliferation, differentiation and gene expression of osteoblasts in boron-containing associated with dexamethasone deliver from mesoporous bioactive glass scaffolds. Biomaterials 2011, 32:7068-7078.
50. Zhang J., Zhou H., Yang K., Yuan Y., Liu C. RhBMP-2-loaded calcium silicate/calcium phosphate cement scaffold with hierarchically porous structure for enhanced bone tissue regeneration. Biomaterials 2013, 34:9381-9392.